Evidence map›Paper›PMID 21904619›Full record

ArticlePloS one2011

IFN-α is constitutively expressed in the human thymus, but not in peripheral lymphoid organs.

Arnaud D Colantonio, Marta Epeldegui, Maria Jesiak, Loes Jachimowski, Bianca Blom, Christel H Uittenbogaart

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sterile production of interferons in the thymus.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Arnaud D ColantonioDepartment of Microbiology, Immunology, and Molecular Genetics, David E. Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Marta Epeldegui
Maria Jesiak
Loes Jachimowski
Bianca Blom
Christel H Uittenbogaart
University of California, Los Angeles · USAcademic Medical Center · NLUniversity of Amsterdam · NL

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
UCLA Tumor Immunology Training ProgramT32CA009120 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Steven M. Dubinett, MICHAEL A TEITELL · 1985 to 2026
$10.3M
IFN-a and pDC in HIV infection: impact on T cell development and reconstitutionR01AI080564 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 2009 to 2013
$2.0M
HIV and Plasmacytoid dendritic cells in the thymusR01AI052002 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 2004 to 2007
$1.5M
Academic Training in RheumatologyT32AR053463 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGH, RAM RAJ · 2007 to 2011
$1.1M
HIV and Plasmacytoid dendritic cells in the thymusR21AI052002 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 2002 to 2002
$290k
NCI NIH HHS T32 CA009120NCI NIH HHS T32-CA-009120NIAID NIH HHS AI 080564NIAID NIH HHS AI 28697NIAID NIH HHS AI 52002NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI052002NIAID NIH HHS R01 AI080564NIAID NIH HHS R21 AI052002NIAMS NIH HHS T32 AR053463NIAMS NIH HHS T32-AR-053463
6 · The paper itself

Abstract

Type I interferons have been typically studied for their effects in the context of bacterial or viral infections. However in this report, we provide evidence that Interferon-alpha (IFN-α) expressing cells are present in the thymus in the absence of infection. We show that pDC express the highest level of IFN-α and that MxA, which is exclusively expressed after engagement of the type I IFN receptor by IFN-α/β, is expressed in normal fetal and post-natal thymus, but not in the periphery. The highest level of MxA is expressed in mature thymocytes and pDC located in the medulla and at the cortico-medullary junction. The anti-microbial peptide LL-37, which is expressed in the thymus, when complexed with eukaryotic nucleic acids, induces the secretion of IFN-α by thymic pDC. This results in the upregulation of MxA expression in responsive thymocytes. We propose that the secretion of IFN-α in the thymus may function to regulate the rate of T cell development and modulate the requirements for the selection of developing T cells.

Indexed as

Cells, CulturedFlow CytometryGTP-Binding ProteinsHumansImmunohistochemistryInterferon-alphaInterferon Regulatory Factor-7LiverLymphoid TissueMicroscopy, FluorescenceMyxovirus Resistance ProteinsReal-Time Polymerase Chain ReactionSTAT1 Transcription FactorThymocytesThymus GlandGTP-Binding ProteinsInterferon-alphaInterferon Regulatory Factor-7MX1 protein, humanMyxovirus Resistance ProteinsSTAT1 Transcription Factor

Identifiers

PMID21904619
PMCPMC3164161
OpenAlexW2161187364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.